MicroRNAs as potential pharmaco-targets in ischemia-reperfusion injury compounded by diabetes H Dehaini, H Awada, A El-Yazbi, FA Zouein, K Issa, AA Eid, M Ibrahim, ... Cells 8 (2), 152, 2019 | 51 | 2019 |
Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study NJ Atallah, HM Warren, MB Roberts, RH Elshaboury, MR Bidell, ... PloS one 17 (1), e0262342, 2022 | 40 | 2022 |
Genomic Assays in Node Positive Breast Cancer Patients: A Review. Front M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi Oncol 10, 3461, 2021 | 24 | 2021 |
The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis. MK Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ... Hepatology Communications 7 (10), e0263-e0263, 2023 | 8 | 2023 |
Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD O Balogun, JY Wang, ES Shaikh, K Liu, S Stoyanova, ZN Memel, ... Hepatology Communications 7 (11), e0300, 2023 | 6 | 2023 |
Arrhythmias in Neonates and Infants at a Tertiary Care Center M Refaat, MM Abohelwa, M Ahmed, A Elgehiny, M Ibrahim, P Zakka, ... Cureus 13 (1), 2021 | 4 | 2021 |
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers MK Ibrahim, TG Simon, ME Rinella Clinics in Liver Disease, 2023 | 3 | 2023 |
ARRHYTHMIAS IN NEONATES AND INFANTS AT A TERTIARY CARE CENTER M Abohelwa, M Refaat, MA Ahmed, M Ibrahim, A Elgehiny, P Zakka, ... Journal of the American College of Cardiology 77 (18_Supplement_1), 397-397, 2021 | 1 | 2021 |
Su1596 HEPATIC STEATOSIS IDENTIFICATION: A COMPREHENSIVE APPROACH USING NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING IN RADIOLOGY REPORTS O Balogun, ES Shaikh, L Mun, M Michta, MK Ibrahim, EU Anya, KE Corey Gastroenterology 166 (5), S-1656-S-1657, 2024 | | 2024 |
Sa1579 TOBACCO USE SYNERGISTICALLY INCREASED THE RISK OF HEPATIC FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS WITH TYPE 2 DIABETES MELLITUS O Balogun, ES Shaikh, KT Liu, J Wang, S Stoyanova, H Schultz, ... Gastroenterology 164 (6), S-1302, 2023 | | 2023 |
S3342 Inpatient Initiation of Pharmacotherapy for Obesity to Improve Liver Transplant Eligibility: A Case Report M Ibrahim, M Conrath, G Dicarlo, E Bethea, D Back Official journal of the American College of Gastroenterology| ACG 117 (10S …, 2022 | | 2022 |
THE EMPIRICAL DIETARY INFLAMMATORY PATTERN SCORE AND THE RISK OF NAFLD AND CIRRHOSIS M Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ... HEPATOLOGY 76, S712-S713, 2022 | | 2022 |
THE EMPIRICAL DIETARY INFLAMMATORY PATTERN SCORE AND THE RISK OF CARDIOVASCULAR DISEASE IN PATIENTS WITH NAFLD M Ibrahim, RM Wilechansky, PK Challa, X Zhang, E Giovannucci, ... HEPATOLOGY 76, S713-S714, 2022 | | 2022 |
Genomic Assays in Node Positive Breast Cancer Patients: A Review (vol 10, 609100, 2021) M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi FRONTIERS IN ONCOLOGY 11, 2021 | | 2021 |
Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review M Bou Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi Frontiers in Oncology 11, 1255, 2021 | | 2021 |
Arrhythmias in Neonates and Infants at a Tertiary Care Center A Muacevic, J Adler, M Refaat, M Abohelwa, M Ahmed, A Elgehiny, ... Cureus 13 (1), 2021 | | 2021 |
Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review M Ibrahim, C El Nakib, R Hajjar, H Assi Frontiers in Oncology 11, 2021 | | 2021 |
Genomic Assays in Node Positive Breast Cancer Patients: A Review MB Zerdan, M Ibrahim, C El Nakib, R Hajjar, HI Assi Frontiers in Oncology 10, 2020 | | 2020 |
Extrahepatic and Hepatic Cancers M Ibrahim, TG Simon Need-to-Know NAFLD, 183-194, 0 | | |